Clinical Drug Experience Knowledgebase

Adenocarcinoma (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 1)

Carcinoma, Squamous Cell (Phase 1)

Carcinoma, Transitional Cell (Phase 2)

Cholangiocarcinoma (Phase 1)

Disease Progression (Phase 2)

Gallbladder Neoplasms (Phase 1)

Leukemia (Phase 1)

Leukemia, Lymphoid (Phase 1)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 1)

Leukemia, Myeloid (Phase 1)

Leukemia, Myeloid, Acute (Phase 1)

Lung Neoplasms (Phase 1)

Myelodysplastic-Myeloproliferative Diseases (Phase 1)

Myelodysplastic Syndromes (Phase 1)

Myeloproliferative Disorders (Phase 1)

Neoplasms (Phase 1)

Pancreatic Neoplasms (Phase 1)

Philadelphia Chromosome (Phase 1)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)

Prostatic Neoplasms (Phase 2)

Sarcoma (Phase 2)

Sarcoma, Kaposi (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Phase 1)